Amedeo Smart

Free Medical Literature Service

 

Amedeo

Breast Cancer
  Free Subscription

Articles published in
Radiother Oncol
    October 2025
  1. BELARDO A, Dimayuga KB, Perna L, Fodor A, et al
    Density and volume of cardiac calcifications detected on planning CT predicts cardiotoxicity after hypo-fractionated whole breast Radiotherapy.
    Radiother Oncol. 2025;211:111098.
    >> Share

  2. NG S, Kilburn LS, Kirby AM, Griffin C, et al
    Five-year trends and baseline predictors of patient-reported adverse events following breast radiotherapy with a boost in the IMPORT HIGH phase III randomised controlled trial.
    Radiother Oncol. 2025;211:111056.
    >> Share

    September 2025
  3. JOSEPH K, Ademola A, Zebak J, Singh A, et al
    Adjuvant radiotherapy alone, an effective treatment option for early-stage low- risk breast cancer in women over 50: results from a population based cohort study using a Canadian provincial database.
    Radiother Oncol. 2025 Sep 29:111175. doi: 10.1016/j.radonc.2025.111175.
    >> Share

  4. THOMSEN MS, Lorenzen EL, Alsner J, Krogh SL, et al
    Quality assessment of 2705 treatment plans in the randomised Danish Breast Cancer Group Skagen trial 1.
    Radiother Oncol. 2025 Sep 15:111142. doi: 10.1016/j.radonc.2025.111142.
    >> Share

  5. WANG DQ, Yan L, Wu HF, Zhong YH, et al
    Prospective cohort study to validate esophageal dose constraints and predictive models for esophagitis in patients with breast cancer undergoing hypofractionated regional nodal radiotherapy.
    Radiother Oncol. 2025;212:111120.
    >> Share

    August 2025
  6. OLIVEROS S, Goyal A, Dodwell D
    The impact of radiotherapy on trials of axillary management in early breast cancer.
    Radiother Oncol. 2025 Aug 6:111054. doi: 10.1016/j.radonc.2025.111054.
    >> Share

  7. NELISSEN SH, Young-Afat DA, Bongard HJGDVD, Coert JH, et al
    Neoadjuvant radiotherapy and immediate breast reconstruction: A systematic review of literature of the last decade.
    Radiother Oncol. 2025;209:110991.
    >> Share

  8. KAIDAR-PERSON O, Poortmans P, Meattini I, Tramm T, et al
    An additional peril of pathologic complete response.
    Radiother Oncol. 2025;209:110962.
    >> Share

  9. HORBERGER F, Petersson K, Ceberg S, Back S, et al
    Investigating the therapeutic potential of FLASH radiotherapy - a treatment planning study.
    Radiother Oncol. 2025;209:110947.
    >> Share

    July 2025
  10. PUTORA PM, Henke G, Bese N, Boersma L, et al
    What guides regional nodal irradiation in node positive breast cancer following upfront sentinel lymph node biopsy?
    Radiother Oncol. 2025 Jul 20:111055. doi: 10.1016/j.radonc.2025.111055.
    >> Share

  11. BOERSMA LJ, Hessels A, Roberti S, Seravall E, et al
    Selection of patients for proton therapy to reduce risk of second primary lung and breast cancer.
    Radiother Oncol. 2025 Jul 4:110998. doi: 10.1016/j.radonc.2025.110998.
    >> Share

  12. GUCKENBERGER M, Wilke L, Billiet C, Rogers S, et al
    Dose-intensified SBRT for vertebral oligometastases: results from a prospective clinical trial.
    Radiother Oncol. 2025;208:110940.
    >> Share

    June 2025
  13. BRUNT AM, Cafferty FH, Wheatley D, Sydenham MA, et al
    Patient- and clinician-assessed five-year normal tissue effects following one-week versus three-week axillary radiotherapy for breast cancer: Results from the phase III FAST-Forward trial randomised nodal sub-study.
    Radiother Oncol. 2025;207:110915.
    >> Share

  14. NIELSEN AWM, Thorsen LBJ, Ozcan D, Matthiessen LW, et al
    Local recurrence with and without a tumour-bed boost: A post-hoc analysis of the DBCG IMN2 study.
    Radiother Oncol. 2025;207:110905.
    >> Share

    May 2025
  15. PRADES-SAGARRA E, Geurts FAP, Biemans R, Lieuwes NG, et al
    The radiosensitizing effect of Caffeic Acid Phenethyl Ester in breast cancer is dependent on p53 status.
    Radiother Oncol. 2025;209:110945.
    >> Share

  16. KIM S, Jeon SH, Kim Y, Park N, et al
    TIGIT blockade increases efficacy of PD-1 blockade combined with radiation therapy in triple-negative breast cancer model.
    Radiother Oncol. 2025 May 11:110932. doi: 10.1016/j.radonc.2025.110932.
    >> Share

  17. CALUWE A, Bellal S, Cao K, Peignaux K, et al
    Adapting radiation therapy to immunotherapy: Delineation and treatment planning of pre-operative immune-modulating breast iSBRT in 151 patients treated in the randomized phase II Neo-CheckRay trial.
    Radiother Oncol. 2025;206:110836.
    >> Share

    March 2025
  18. BRION T, Ghodssighassemabadi R, Auzac G, Kirova Y, et al
    Early toxicity of moderately hypofractionated radiation therapy in breast cancer patients receiving locoregional irradiation: First results of the UNICANCER HypoG-01 phase III trial.
    Radiother Oncol. 2025;207:110849.
    >> Share

  19. VINCENZI MM, Cicchetti A, Castriconi R, Mangili P, et al
    Training and temporally validating an NTCP model of acute toxicity after whole breast radiotherapy, including the impact of advanced delivery techniques.
    Radiother Oncol. 2025;204:110700.
    >> Share

    February 2025
  20. BYUN HK, Kim H, Son J, Cho Y, et al
    Impact of bra application in breast cancer radiotherapy: A pilot prospective randomized trial.
    Radiother Oncol. 2025;206:110785.
    >> Share

    January 2025
  21. CHUFAL KS, Ahmad I, Miller AA, Bajpai R, et al
    Machine learning model for predicting DIBH non-eligibility in left-sided breast cancer radiotherapy: Development, validation and clinical impact analysis.
    Radiother Oncol. 2025;205:110764.
    >> Share

  22. EOM A, Kirkwood D, Pond G, Hodgson N, et al
    Radiation therapy and immigration status in women with breast cancer.
    Radiother Oncol. 2025 Jan 31:110774. doi: 10.1016/j.radonc.2025.110774.
    >> Share

  23. YEH J, Tacey M, Harris B, Lau E, et al
    Stabilised hyaluronic acid gel marker versus surgical clips for tumour bed delineation in breast cancer radiotherapy using MRI-simulation.
    Radiother Oncol. 2025;205:110749.
    >> Share

  24. MOSHE N, Haisraely O, Globus O, Faermann R, et al
    Breast cancer outcomes after skin- and nipple-sparing mastectomy in BRCA pathogenic mutation carriers versus non-BRCA carriers.
    Radiother Oncol. 2025;205:110710.
    >> Share

  25. REFSGAARD L, Buhl ES, Nielsen AWM, Thomsen MS, et al
    Quality assurance of internal mammary node irradiation in the DBCG IMN2 study.
    Radiother Oncol. 2025;202:110600.
    >> Share

  26. CHUNG CV, Khan MS, Olanrewaju A, Pham M, et al
    Knowledge-based planning for fully automated radiation therapy treatment planning of 10 different cancer sites.
    Radiother Oncol. 2025;202:110609.
    >> Share

    December 2024
  27. REFSGAARD L, Holm Milo ML, Buhl ES, Jensen JM, et al
    The effect of coronary artery calcifications and radiotherapy on the risk of coronary artery disease in high-risk breast cancer patients in the DBCG RT-Nation cohort.
    Radiother Oncol. 2024 Dec 24:110705. doi: 10.1016/j.radonc.2024.110705.
    >> Share

  28. LATORRE-MUSOLL A, Oses G, Antelo G, Serrano-Rueda S, et al
    Transit-guided radiation therapy: a novel patient monitoring approach.
    Radiother Oncol. 2024;201:110580.
    >> Share

  29. THOMSEN MS, Alsner J, Lutz CM, Berg M, et al
    Breast induration and irradiated volume in the DBCG HYPO trial: The impact of age, smoking, and boost.
    Radiother Oncol. 2024;201:110574.
    >> Share

  30. GUINOT JL, Gutierrez-Miguelez C, Meszaros N, Gonzalez-Perez V, et al
    Five-year results of the very accelerated partial breast irradiation VAPBI phase I-II GEC-ESTRO trial.
    Radiother Oncol. 2024;201:110543.
    >> Share

    November 2024
  31. KUBECZKO M, Gabrys D, Rembak-Szynkiewicz J, Graupner D, et al
    Efficacy of radiotherapy for bone metastasis in breast cancer patients treated with cyclin-dependent kinase 4/6 inhibitors.
    Radiother Oncol. 2024 Nov 18:110639. doi: 10.1016/j.radonc.2024.110639.
    >> Share

  32. BUHL ES, Refsgaard LH, Al-Rawi SA, Andersen K, et al
    Population based audit of heart radiation doses in 6925 high-risk breast cancer patients from the Danish breast cancer group RT Nation study.
    Radiother Oncol. 2024 Nov 16:110643. doi: 10.1016/j.radonc.2024.110643.
    >> Share

  33. VAN SCHIE P, Huisman RG, Wiersma T, Knegjens JL, et al
    Local control and toxicity after stereotactic radiotherapy in brain metastases patients and the impact of novel systemic treatments.
    Radiother Oncol. 2024;200:110540.
    >> Share

  34. BOUTRY C, Moreau NN, Jaudet C, Lechippey L, et al
    Machine learning and deep learning prediction of patient specific quality assurance in breast IMRT radiotherapy plans using Halcyon specific complexity indices.
    Radiother Oncol. 2024;200:110483.
    >> Share

  35. SMINE Z, Poeta S, De Caluwe A, Desmet A, et al
    Automated segmentation in planning-CT for breast cancer radiotherapy: A review of recent advances.
    Radiother Oncol. 2024;202:110615.
    >> Share

    October 2024
  36. DE ROSE F, Carmen De Santis M, Lucidi S, Ray Colciago R, et al
    Dose constraints in breast cancer radiotherapy. A critical review.
    Radiother Oncol. 2024 Oct 18:110591. doi: 10.1016/j.radonc.2024.110591.
    >> Share

  37. KAIDAR-PERSON O, Ratosa I, Franco P, Masiello V, et al
    The Assisi think tank focus review on postoperative radiation for lobular breast cancer.
    Radiother Oncol. 2024 Oct 10:110573. doi: 10.1016/j.radonc.2024.110573.
    >> Share

  38. BUHL ES, Lorenzen EL, Refsgaard L, Nielsen AWM, et al
    Development and comprehensive evaluation of a national DBCG consensus-based auto-segmentation model for lymph node levels in breast cancer radiotherapy.
    Radiother Oncol. 2024;201:110567.
    >> Share

  39. ALI T, Vellengara M, Albalushi FY, Basheer R, et al
    Deep Inspiration breath Hold facilitates surgical cavity registration on cone beam imaging for Partial breast irradiation.
    Radiother Oncol. 2024;199:110471.
    >> Share

  40. ALONGI F, Nicosia L, Ricardi U, Scorsetti M, et al
    Acute toxicity in patients with oligometastatic cancer following metastasis-directed stereotactic body radiotherapy: An interim analysis of the E(2)-RADIatE OligoCare cohort.
    Radiother Oncol. 2024;199:110466.
    >> Share

  41. JOHNSON PB, Mamalui M, Brodin P, Janssens G, et al
    Secondary cancer risk in six anatomical sites when using PAT, IMPT, and VMAT/IMRT radiotherapy.
    Radiother Oncol. 2024;199:110421.
    >> Share

    September 2024
  42. KAIDAR-PERSON O, Boersma L, De Brouwer P, Weltens C, et al
    The EORTC 22922/10925 trial investigating regional nodal irradiation in stage I-III breast cancer: Outcomes according to locoregional and systemic therapies.
    Radiother Oncol. 2024 Sep 26:110563. doi: 10.1016/j.radonc.2024.110563.
    >> Share

  43. GROOT KOERKAMP M, Stijnman P, Houweling A, Zachiu C, et al
    Automated dose evaluation on daily cone-beam computed tomography for breast cancer patients.
    Radiother Oncol. 2024;200:110541.
    >> Share

    August 2024
  44. LAVIGNE D, Hijal T, Vavassis P, Guilbert MC, et al
    Single preoperative radiation therapy with delayed surgery for low-risk breast cancer: Oncologic outcome, toxicity and cosmesis of the SPORT-DS phase I trial.
    Radiother Oncol. 2024;200:110515.
    >> Share

  45. MAHMOUD D, Yassa M, Alvarado L, Lambert C, et al
    Single pre-operative radiation therapy (SPORT-CK) trial for low-risk breast cancer: Early results of a phase 2 study.
    Radiother Oncol. 2024;200:110510.
    >> Share

  46. KIM Y, Jeon SH, Kim S, Kang MH, et al
    In vitro-irradiated cancer vaccine enhances anti-tumor efficacy of radiotherapy and PD-L1 blockade in a syngeneic murine breast cancer model.
    Radiother Oncol. 2024;200:110480.
    >> Share

  47. ALKNER S, Wieslander E, Lundstedt D, Berg M, et al
    Quality assessment of radiotherapy in the prospective randomized SENOMAC trial.
    Radiother Oncol. 2024;197:110372.
    >> Share

  48. FRANCESCHINI D, Teriaca MA, Mancosu P, Bertolini A, et al
    Prospective phase II trial on ablative stereotactic body radiation therapy (SBRT) for medically inoperable thoracic nodes metastases.
    Radiother Oncol. 2024;197:110335.
    >> Share

    July 2024
  49. CHUN SJ, Kim K, Kim YB, Paek SH, et al
    Risk of radionecrosis in HER2-positive breast cancer with brain metastasis receiving trastuzumab emtansine (T-DM1) and brain stereotactic radiosurgery.
    Radiother Oncol. 2024;199:110461.
    >> Share

  50. BOERSMA LJ, Bijker N, Stam MR
    Reporting breast cancer radiation therapy details in studies and daily practice: Nice-to-have or a must-have?
    Radiother Oncol. 2024 Jul 17:110429. doi: 10.1016/j.radonc.2024.110429.
    >> Share

  51. OVERGAARD J, Ccm Hulshof M, Dahl O, Arcangeli G, et al
    ESHO 1-85. Hyperthermia as an adjuvant to radiation therapy in the treatment of locally advanced breast carcinoma. A randomized multicenter study by the European Society for Hyperthermic Oncology.
    Radiother Oncol. 2024;196:110313.
    >> Share

    June 2024
  52. SONG YC, Chen SY, Zhao XR, Jing H, et al
    Prognostic value of lymphocytes in patients with breast cancer receiving radiotherapy after breast-conserving surgery: A post hoc analysis of a phase III randomized trial.
    Radiother Oncol. 2024 Jun 17:110390. doi: 10.1016/j.radonc.2024.110390.
    >> Share

  53. CACHO-DIAZ B, Valdes-Ferrer SI, Chavez-MacGregor M, Salmeron-Moreno K, et al
    Brain metastasis risk prediction model in females with hormone receptor-positive breast cancer.
    Radiother Oncol. 2024 Jun 9:110379. doi: 10.1016/j.radonc.2024.110379.
    >> Share

  54. CHRIST SM, Alongi F, Ricardi U, Scorsetti M, et al
    Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease: An interim analysis of the EORTC-ESTRO E(2)-RADIatE OligoCare study.
    Radiother Oncol. 2024;195:110235.
    >> Share

    May 2024
  55. HOGSBJERG KW, Offersen BV
    Author's response to Letter-to-the-Editor from Chang JS. concerning: "Benefit of respiratory gating in the Danish Breast Cancer Group partial breast irradiation trial".
    Radiother Oncol. 2024;197:110351.
    >> Share

  56. CHEN F, Zhou P, Ren G, Lee EKW, et al
    Interpretable deep learning insights: Unveiling the role of 1 Gy volume on lymphopenia after radiotherapy in breast cancer.
    Radiother Oncol. 2024;197:110333.
    >> Share

  57. HANNOUN-LEVI JM, Gimeno Morales M, Gal J, Anchuelo J, et al
    Very accelerated partial breast irradiation in 1 or 2 days: Late toxicity and early oncological outcome of the GEC-ESTRO VAPBI cohort.
    Radiother Oncol. 2024;194:110217.
    >> Share

  58. CICCHETTI A, Mangili P, Fodor A, Gabellini MGU, et al
    Skin dose-volume predictors of moderate-severe late side effects after whole breast radiotherapy.
    Radiother Oncol. 2024;194:110183.
    >> Share

    April 2024
  59. REFSGAARD L, Skarso Buhl E, Yates E, Maae E, et al
    Evaluating Danish Breast Cancer Group locoregional radiotherapy guideline adherence in clinical treatment data 2008-2016: The DBCG RT Nation study.
    Radiother Oncol. 2024 Apr 25:110289. doi: 10.1016/j.radonc.2024.110289.
    >> Share

    March 2024
  60. FRANCESCHINI D, Franzese C, Comito T, Ilieva MB, et al
    Definitive results of a prospective non-randomized phase 2 study on stereotactic body radiation therapy (sbrt) for medically inoperable lung and liver oligometastases from breast cancer.
    Radiother Oncol. 2024;195:110240.
    >> Share

  61. HUIJSKENS S, Granton P, Fremeijer K, van Wanrooij C, et al
    Clinical practicality and patient performance for surface-guided automated VMAT gating for DIBH breast cancer radiotherapy.
    Radiother Oncol. 2024 Mar 14:110229. doi: 10.1016/j.radonc.2024.110229.
    >> Share

  62. KUBECZKO M, Jarzab M, Gabrys D, Krzywon A, et al
    Corrigendum to "Safety and feasibility of CDK4/6 inhibitors treatment combined with radiotherapy in patients with HR-positive/HER2-negative breast cancer. A systematic review and meta-analysis" [Radiother. Oncol. 187 (2023) 109839].
    Radiother Oncol. 2024;194:110188.
    >> Share

  63. HOGSBJERG KW, Maae E, Nielsen MH, Stenbygaard L, et al
    Benefit of respiratory gating in the Danish Breast Cancer Group partial breast irradiation trial.
    Radiother Oncol. 2024 Mar 3:110195. doi: 10.1016/j.radonc.2024.110195.
    >> Share

  64. GIMENO-MORALES M, Martinez-Monge R, Martinez-Lage A, Jablonska PA, et al
    Long-term results of intraoperative multicatheter breast implant (IOMBI) for accelerated partial breast irradiation (APBI) on early breast cancer patients.
    Radiother Oncol. 2024;194:110193.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016